{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:30:46Z","timestamp":1772461846028,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Joint Funds for the innovation of science and Technology\uff0cFujian province","award":["2023Y9379"],"award-info":[{"award-number":["2023Y9379"]}]},{"name":"Joint Funds for the innovation of science and Technology\uff0cFujian province","award":["2023Y9379"],"award-info":[{"award-number":["2023Y9379"]}]},{"name":"Joint Funds for the innovation of science and Technology\uff0cFujian province","award":["2023Y9379"],"award-info":[{"award-number":["2023Y9379"]}]},{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2023QH1194"],"award-info":[{"award-number":["2023QH1194"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Human Papillomavirus (HPV) infection is a significant public health concern, particularly during pregnancy. The impact of HPV infection during pregnancy on maternal and child health is a growing concern. However, research on infection rate and pregnancy outcomes of nine-valent vaccine-covered and non-covered high-risk HPV subtypes during pregnancy remains limited. A retrospective cohort study involved 7110 pregnant women who underwent HPV testing in Fujian Provincial Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University (FMCH) from January 2021 to December 2022. Multiple logistic regression analyses investigated the association between HPV infections and maternal and neonatal outcomes. The study identified that the overall HPV infection rate in pregnant women was 19.9%. The HPV types 52, 16, 58, 42, and 51 were the most common among the participants. Infections with nine-valent HPV vaccine-covered high-risk subtypes significantly increased the risk of preterm premature rupture of membranes (PPROM) (OR\u2009=\u20091.29; 95% CI: 1.08\u20131.55) and cesarean section (OR\u2009=\u20091.25; 95% CI: 1.06\u20131.49). Co-infections with both nine-valent vaccine-covered and non-covered high-risk HPV subtypes elevated the risks of cesarean section (OR\u2009=\u20091.59; 95% CI: 1.11\u20132.27) and hypertensive disorders of pregnancy (OR\u2009=\u20092.73; 95% CI: 1.44\u20135.15). Additionally, these infections significantly increased the risk of small for gestational age (SGA) infants, with the group IV (OR\u2009=\u20092.07; 95% CI: 1.21\u20133.54) having a higher risk than the group III (OR\u2009=\u20091.33; 95% CI: 0.17\u20131.65). Moreover, those neonates who were born to mothers with HPV co-infections had a significantly higher risk of ICU admission (OR\u2009=\u20091.58; 95% CI: 1.01\u20132.49). This study revealed the significant association between specific HPV infections during pregnancy and adverse maternal and neonatal outcomes. These findings underscore the importance of monitoring HPV infections during pregnancy and suggest that an enhanced rate of the nine-valent HPV vaccine and strengthen the development and application of the non-nine-valent HPV vaccine could improve maternal\u2013fetal health outcomes.<\/jats:p>","DOI":"10.1038\/s41598-025-94563-4","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T23:35:44Z","timestamp":1742859344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The distribution and the relationship of HPV subtypes infection with pregnancy outcomes"],"prefix":"10.1038","volume":"15","author":[{"given":"Yingying","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinye","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjie","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"issue":"4","key":"94563_CR1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C De Martel","year":"2017","unstructured":"De Martel, C. et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int. J. Cancer 141(4), 664\u2013670 (2017).","journal-title":"Int. J. Cancer"},{"issue":"2","key":"94563_CR2","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","volume":"35","author":"DJ Wiley","year":"2002","unstructured":"Wiley, D. J. et al. External genital warts: Diagnosis, treatment, and prevention. Clin. Infect. Dis. 35(2), S210\u2013S224 (2002).","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"94563_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","volume":"40","author":"CL Satterwhite","year":"2013","unstructured":"Satterwhite, C. L. et al. Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sex. Transm. Dis. 40(3), 187\u2013193 (2013).","journal-title":"Sex. Transm. Dis."},{"issue":"19","key":"94563_CR4","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland, S. M. et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 356(19), 1928\u20131943 (2007).","journal-title":"N. Engl. J. Med."},{"issue":"9446","key":"94563_CR5","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","volume":"364","author":"AB Moscicki","year":"2004","unstructured":"Moscicki, A. B. et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 364(9446), 1678\u20131683 (2004).","journal-title":"Lancet."},{"issue":"7","key":"94563_CR6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1158\/1055-9965.EPI-06-0129","volume":"15","author":"H Trottier","year":"2006","unstructured":"Trottier, H. et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev. 15(7), 1274\u20131280 (2006).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"19","key":"94563_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.46234\/ccdcw2024.080","volume":"6","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Estimated human papillomavirus vaccine coverage among females 9\u201345 years of age - China, 2017\u20132022. China CDC Wkly. 6(19), 413\u2013417 (2024).","journal-title":"China CDC Wkly."},{"issue":"3","key":"94563_CR8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith, J. S. et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int. J. Cancer. 121(3), 621\u2013632 (2007).","journal-title":"Int. J. Cancer."},{"key":"94563_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-173","author":"G Cho","year":"2013","unstructured":"Cho, G. et al. High-risk human papillomavirus infection is associated with premature rupture of membranes. BMC Pregnancy Childbirth https:\/\/doi.org\/10.1186\/1471-2393-13-173 (2013).","journal-title":"BMC Pregnancy Childbirth"},{"issue":"12","key":"94563_CR10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/infdis\/jiaa054","volume":"221","author":"J Niyibizi","year":"2020","unstructured":"Niyibizi, J. et al. Association between maternal human papillomavirus infection and adverse pregnancy outcomes: Systematic review and meta-analysis. J. Infect Dis. 221(12), 1925\u20131937 (2020).","journal-title":"J. Infect Dis."},{"issue":"2","key":"94563_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767058.2017.1378330","volume":"32","author":"JH Ford","year":"2017","unstructured":"Ford, J. H. et al. Human papillomavirus infection and intrauterine growth restriction: A data-linkage study. J. MATERN-FETAL NEO M. 32(2), 279\u2013285 (2017).","journal-title":"J. MATERN-FETAL NEO M."},{"issue":"1","key":"94563_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13643-017-0443-5","volume":"6","author":"J Niyibizi","year":"2017","unstructured":"Niyibizi, J. et al. The association between adverse pregnancy outcomes and maternal human papillomavirus infection: A systematic review protocol. Syst. Rev. 6(1), 53 (2017).","journal-title":"Syst. Rev."},{"issue":"184","key":"94563_CR13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.24976\/Discov.Med.202436184.91","volume":"36","author":"Y Liu","year":"2024","unstructured":"Liu, Y. & Wang, S. Genotype distribution and prevalence of high-risk human papillomavirus among pregnant women and maternal-fetal pregnancy outcomes in a tertiary hospital in Beijing China. Discov Med. 36(184), 981\u2013991 (2024).","journal-title":"Discov Med."},{"issue":"10","key":"94563_CR14","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/aogs.14913","volume":"103","author":"D Kov\u00e1cs","year":"2024","unstructured":"Kov\u00e1cs, D. et al. Association between human papillomavirus and preterm delivery: A systematic review and meta-analysis. Acta Obstet Gyn Scan. 103(10), 1933\u20131942 (2024).","journal-title":"Acta Obstet Gyn Scan."},{"issue":"5","key":"94563_CR15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000482008","volume":"83","author":"YQ Xiong","year":"2018","unstructured":"Xiong, Y. Q. et al. The risk of human papillomavirus infection for spontaneous abortion, spontaneous preterm birth, and pregnancy rate of assisted reproductive technologies: A systematic review and meta-analysis. Gynecol Obstet. Inves. 83(5), 417\u2013427 (2018).","journal-title":"Gynecol Obstet. Inves."},{"issue":"2","key":"94563_CR16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/AOG.0000000000001247","volume":"127","author":"A Subramaniam","year":"2016","unstructured":"Subramaniam, A. et al. Evaluation of human papillomavirus as a risk factor for preterm birth or pregnancy-related hypertension. Obstet. Gynecol. 127(2), 233\u2013240 (2016).","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"94563_CR17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ejogrb.2013.07.002","volume":"170","author":"L Conde-Ferr\u00e1ez","year":"2013","unstructured":"Conde-Ferr\u00e1ez, L. et al. Human papillomavirus infection and spontaneous abortion: A case-control study performed in Mexico. Eur. J. Obstet. Gyn. Reprod. Biol. 170(2), 468\u2013473 (2013).","journal-title":"Eur. J. Obstet. Gyn. Reprod. Biol."},{"key":"94563_CR18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12935-020-01512-4","volume":"20","author":"B Dong","year":"2020","unstructured":"Dong, B. et al. Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: An observational cohort study. Cancer Cell Int. 20, 421 (2020).","journal-title":"Cancer Cell Int."},{"issue":"3","key":"94563_CR19","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e29","volume":"30","author":"Y Kang","year":"2019","unstructured":"Kang, Y. et al. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort. J. Gynecol. Oncol. 30(3), e29 (2019).","journal-title":"J. Gynecol. Oncol."},{"issue":"5","key":"94563_CR20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003641","volume":"18","author":"J Wiik","year":"2021","unstructured":"Wiik, J. et al. Associations of treated and untreated human papillomavirus infection with preterm delivery and neonatal mortality: A Swedish population-based study. PLoS Med. 18(5), e1003641 (2021).","journal-title":"PLoS Med."},{"issue":"3","key":"94563_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/aogs.14509","volume":"102","author":"J Wiik","year":"2023","unstructured":"Wiik, J. et al. Maternal human papillomavirus infection during pregnancy and preterm delivery: A mother-child cohort study in Norway and Sweden. Acta Obstet. Gynecol. Scand. 102(3), 344\u2013354 (2023).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"94563_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejogrb.2021.05.037","volume":"262","author":"X Xu","year":"2021","unstructured":"Xu, X. et al. Has the human papillomavirus (HPV) immunization programme improved obstetric outcomes in spontaneous delivery? An ecological study. Eur. J. Obstet. Gynecol. Reprod. Biol. 262, 221\u2013227 (2021).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"94563_CR23","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2005.09.054","volume":"24","author":"H Trottier","year":"2006","unstructured":"Trottier, H. & Franco, E. L. The epidemiology of genital human papillomavirus infection. Vaccine 24, S1-15 (2006).","journal-title":"Vaccine"},{"issue":"2","key":"94563_CR24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2019.10.018","volume":"156","author":"S Dilley","year":"2020","unstructured":"Dilley, S., Miller, K. M. & Huh, W. K. Human papillomavirus vaccination: Ongoing challenges and future directions. Gynecol. Oncol. 156(2), 498\u2013502 (2020).","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"94563_CR25","first-page":"101","volume":"10","author":"W Tjalma","year":"2018","unstructured":"Tjalma, W. et al. HPV vaccination coverage in the federal state of Belgium according to regions and their impact. Facts Views Vis Obgyn. 10(2), 101\u2013105 (2018).","journal-title":"Facts Views Vis Obgyn."},{"issue":"55","key":"94563_CR26","volume":"6","author":"K Farhan","year":"2023","unstructured":"Farhan, K. et al. Malaria prevention during pregnancy: Implications for maternal and neonatal health in East Africa. New Microbes New Infect. 6(55), 101186 (2023).","journal-title":"New Microbes New Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94563-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94563-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94563-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T23:36:48Z","timestamp":1742859408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94563-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94563"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94563-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Hospital Ethics Committee of Fujian Provincial Maternity and Children\u2019s Hospital, an affiliated hospital of Fujian Medical University, approved the study (2024KY161). Due to the retrospective nature of the study, the Hospital Ethics Committee of Fujian Provincial Maternity and Children\u2019s Hospital, an affiliated hospital of Fujian Medical University waived the need of obtaining informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"10138"}}